Gilead Sciences Ireland UC

21 products tracked · names used in filings: Gilead Sciences Ireland UC

Upcoming milestones

No upcoming milestones listed.

Recent milestones

No recent milestones.

Products

ProductStatusApproved
🇪🇺Trodelvy
sacituzumab govitecan
Authorised2021-11-22
🇪🇺Hepcludex
bulevirtide
Authorised2020-07-31
🇪🇺Veklury
remdesivir
Authorised2020-07-03
🇪🇺Biktarvy
bictegravir;emtricitabine;tenofovir alafenamide
Authorised2018-06-21
🇪🇺Vosevi
sofosbuvir;velpatasvir;voxilaprevi
Authorised2017-07-26
🇪🇺Vemlidy
tenofovir alafenamide
Authorised2017-01-09
🇪🇺Epclusa
sofosbuvir;velpatasvir
Authorised2016-07-06
🇪🇺Odefsey
emtricitabine;rilpivirine;tenofovir alafenamide
Authorised2016-06-21
🇪🇺Descovy
emtricitabine;tenofovir alafenamide
Authorised2016-04-21
🇪🇺Genvoya
elvitegravir;cobicistat;emtricitabine;tenofovir alafenamide
Authorised2015-11-19
🇪🇺Harvoni
ledispavir;sofosbuvir
Authorised2014-11-17
🇪🇺Zydelig
idelalisib
Authorised2014-09-18
🇪🇺Sovaldi
sofosbuvir
Authorised2014-01-16
🇪🇺Tybost
cobicistat
Authorised2013-09-19
🇪🇺Stribild
elvitegravir;cobicistat;emtricitabine;tenofovir disoproxil
Authorised2013-05-24
🇪🇺Cayston
aztreonam
Authorised2009-09-21
🇪🇺Atripla
efavirenz;emtricitabine;tenofovir disoproxil
Withdrawn2007-12-13
🇪🇺Truvada
emtricitabine;tenofovir disoproxil
Authorised2005-02-20
🇪🇺Emtriva
emtricitabine
Authorised2003-10-24
🇪🇺Hepsera
adefovir dipivoxil
Withdrawn2003-03-06
🇪🇺Viread
tenofovir disoproxil
Authorised2002-02-04

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.